目錄:MedChemExpress LLC>>生化試劑>> Fuzapladib | MCE
CAS | 141283-87-6 | 分子量 | 379.4 |
---|---|---|---|
分子式 | C??H??F?N?O?S | 供貨周期 | 現(xiàn)貨 |
貨號 | HY-19151 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 141283-87-6
產(chǎn)品活性:Fuzapladib (IS-741) is a potent phospholipase A2 inhibitor. Fuzapladib can block the adhesion of inflammatory cells to microvascular endothelial cells, inhibit the infiltration of neutrophils into the pancreas or acute pancreatitis, and has anti-acute pancreatitis effects.
研究領(lǐng)域:Metabolic Enzyme/Protease
作用靶點(diǎn):Phospholipase
In Vitro: Fuzapladib(IS-741)(1 μM, 3 h) can significantly inhibit the adhesion of HL-60 cells to HUVEC under the stimulation of lipopolysaccharide.
In Vivo: Fuzapladib(IS-741)(p.o., 50 mg/kg, 7 days) significantly reduces myeloperoxidase (MPO) activity and mucosal IL-8 levels in rat ileum, reduces polymorphonuclear cells and Mac-1 positivity Infiltration of cells into inflammatory lesions, effectively alleviates trinitrobenzenesulfonic acid (TNBS)-induced ileitis in rats.
相關(guān)產(chǎn)品:Sphingomyelin phosphodiesterase | LCL521 dihydrochloride | C12 NBD Sphingomyelin | Cambinol | Neomycin sulfate | D-Erythro-dihydrosphingosine | (R)-Bromoenol lactone | CCT129957 | Melittin | Alminoprofen | ML-298 | MAFP | N-Stearoylsphingomyelin | Aristolochic acid C | Omeprazole-d3-1 | 3-Nitrocoumarin | Pyrrophenone | m-3M3FBS | Tanshinone I | VU 0364739 hydrochloride | Ecopladib | LY 178002 | Varespladib methyl | ML348 | DL-erythro-Dihydrosphingosine | Folipastatin | FKGK18 | LY-311727 | Tris(2,4-di-tert-butylphenyl)phosphate | 1-Naphthaleneacetic acid
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作。
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)